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Summary
SCL gene disruptions are the most common chromosomal abnormality associated with the
development of T cell acute lymphoblastic leukemia (ALL) . Such disruptions can be the result
of t(1;14) and t(1;7) translocations, as well as a cytogenetically undetectable interstitial deletion
of chromosome 1 . We present here a case of T cell ALL with a t(1;3)(p34;p21) translocation
that also disrupts the SCL locus and leads to dysregulated SCL gene expression . This translocation,
similar to previously reported SCL gene disruptions, appears to have been mediated, at least in
part, by the V(D)J recombinase complex, since cryptic heptamer recognition sequences, as well
as nontemplated N region nucleotide addition, are present at the breakpoints. The t(1;3) also
disrupts a region on chromosome 3 characterized by alternating purine and pyrimidine residues,
which can form a Z-DNA structure, reported to be prone to recombination events . A previously
undescribed, evolutionarily conserved transcript unit is detected within 8 kb of the breakpoint
onchromosome 3 . This report extends the spectrum ofrecognized SCL translocations associated
with T cell ALL, and underscores the contention that dysregulated SCL expression may be a
causal event in T cell ALL .
N
onrandom chromosomal translocations and deletions are
frequently associated with acute leukemia . The most
common structural disruption recognized in T cell acute lym-
phoblastic leukemia (ALL)' occurs within the SCL (also
known as TCL5 or tal-1) (1-4) gene, a member of the basic
domain, helix-loop-helix (bHLH) family of transcription regu-
lators (5) . Several recent surveys have indicated that the SCL
gene is disrupted in -30% of patients with childhood T cell
ALL (6-8) . This disruption results in the expression ofSCL
inT lymphocytes, a cell type whereSCL expression normally
appears to be repressed (3) . To date, SCL rearrangement has
been reported exclusively in T cell ALL, and not in other
types of leukemias or lymphomas (7) . The frequency and
specificity of this disruption, along with the presumed dys-
regulated mRNA expression seen in the cells that undergo
these changes, have led us and others to speculate that dis-
ruption and dysregulation ofSCL may contribute to T cell
leukemogenesis (1, 2, 4, 9) .
Thus far, three types of SCL rearrangements have been
reported to occur in T cell ALL : t(1;14)(p32;g11) and
t(1;7)(p32;g11) translocations (1, 9-12), joining SCL to the
TCRD and TCRB loci, respectively, and a microscopically
undetectable interstitial deletion of chromosome 1juxtaposing
i Abbreviation used in this paper . ALL, acute lymphoblastic leukemia .
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SCL with the SIL gene (6, 13, 14) . All these chromosomal
abnormalities seem to be mediated, at least in part, by the
V(D)J recombinase complex responsible for the generation
of immunologic diversity. Evidence for involvement of the
V(D)J recombinase complex includes the presence of non-
templated orN region nucleotide addition as well as exonucleo-
lytic "nibbling" at the breakpoints, which typically occurs
in the immediate vicinity of approximate heptamer/nonamer
recognition sequences within the SCL locus . Recently, one
ofus (S . C . Raimondi) has described several rare, previously
unreported, nonrandom translocations associated with child-
hood ALL (15) . Two of these patients had, in their leukemic
cells, t(1;3) translocations with breakpoints on chromosome
1 at bands p32-34 . Since the human SCL gene has been
mapped to this region, we studied DNA and RNA from
these two cases to assess whether these translocations physi-
cally altered the SCL gene, and whether SCL was expressed
in the malignant cells .
The leukemic cells of one ofthe two patients demonstrated
both a breakpoint within the SCL locus and SCL mRNA
expression . Sequence analysis of the breakpoint suggested that
this translocation was also mediated, at least in part, through
the action of the V(D)J recombinase system . A previously
undescribed transcript unit was identified on chromosome
3, within 8 kb of the breakpoint .
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Cytogenic Analysis.
￿
Bone marrow (BM) samples were obtained
from two patients withALL enrolled in Total Therapy Studies at
St . Jude Children's Research Hospital . Thesamples were prepared
by a direct method, with or without short-term culture, to obtain
metaphase spreads . Amodified trypsin-Giemsa techniquewas used
forchromosome banding (16) . The identification and classification
of chromosomes followed the International System for Human
Cytogenetic Nomenclature (17) . Written informed consent was
obtained from the patients or parents ; the investigations were ap-
proved by the institution's clinical trials review committee .
NucleicAcid Extraction .
￿
DNA andRNA were extracted from
viably preserved leukemic samplesby theguanidium isothiocyanate
method (18) .
Southern andNorthern Blot Analysis.
￿
DNAsamples (10 itg) were
digested to completion with restriction enzymes using the manufac-
turer's (Bethesda Research Laboratories, Gaithersburg, MD)recom-
mended conditions and size fractionated on0.8%agarose gels. The
denaturedDNA was transferred to a solid matrix (nitrocellulose ;
Schleicher & Schnell, Inc., Keene, NH) by the Southern method
(19) . RNA samples were size fractionated on 1.0% agarose/form-
aldehyde gels and transferred to nitrocellulose (18) . Southern and
Northern blots were hybridized to 'ZP probes labeled by the
random priming method (20), using "Prime-It" (Stratagene, La
Jolla, CA) reagents and protocols . Hybridization was carried out
as previously described (10) ; the blots were washed twicewith 0.1 x
SSC (1x SSC is 0.15 M NaCl and 0.015M sodium citrate) and
0.1% SDS at 52°C for20minand exposed to x-ray film at -70°C
with an intensifying screen .
Genomic Library Construction. Genomic DNA (2 P,g) was
digested to completion with EcoRI, extracted with phenol/chlo-
roform, and ethanol precipitated . One-halfof the EcoRl-digested
genomicDNA was ligated to 1 Fcg of EcoRl-digested, purified,
X Dash (Stratagene) phage arms, in a total volume of 10 pl, at
4°C for 16 h. Thenakedrecombinant phageDNA was packaged
using Gigapack II (Stratagene) extracts and protocols. 106 inde-
pendent recombinant phage were plated with either SRB
(Stratagene) or LE 392 (Stratagene) cells and incubated at either
39°C (SRB cells) or 37°C (LE 392 cells) . Filter lifts, hybridiza-
tions, and plaque purification was performed as described (18) .
DNASequenceAnalysis.
￿
Pertinent genomic fragments were sub-
cloned into plasmid vectors (pBluescript II ; Stratagene) and se-
t(1 ;3)(p34;p21)
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quenced using oligonucleotide primers synthesized on an oligonu-
cleotide synthesizer (380 ; Applied Biosystems, Inc., Foster City,
CA) and Sequenase (US. Biochemical Corp., Cleveland, OH) re-
agents and protocols.
Results
Table 1 .
￿
Clinical and Laboratory Features of Patients with t(1;3)(p34;p21)
SCL Gene Disruption in T Cell Acute Lymphoblastic Leukemia
The t(1;3)(p34;p21) in a T Cell ALL Patient Has an SCL
Breakpoint. The clinical and laboratory features of the two
patients with a t(1;3) in their leukemic blasts have been
presented elsewhere (15), and are only briefly recapitulated
here (Table 1) . One of these patients (patient 1) had aT cell
immunophenotype; theother (patient 2) had an early pre-B
immunophenotype . The assignment of the breakpoints on
chromosome 1 was difficult because the band definition of
this 1p region is ambiguous (Fig. 1) . We have previously
characterized genomic and cDNA probes from two genes
mapped to 1p32-34: SIL (14) and SCL (1, 3, 10) . Southern
blots of genomicDNA extracted from the leukemic blasts
of both patients were hybridized to several probes from these
two loci ; the SCL probes (0.3B2, 0.3N, 2.2XX, and 1.OSX)
areshown in Fig . 2B. A5' SCLprobe (0.3N) identified novel
rearranged bands inBamHI, EcoRI, PstI, andHindIII digests
of genomicDNA from patient 1's leukemic blasts ; a unique
17-kb HindIII fragment, as well as the germline 21-kb band,
are shown in Fig . 2A . Comparison of the Southern blot
data with a genomic SCL restriction map suggested that the
breakpoint should be -2 kb centromeric to the0.3N probe .
In agreement with this prediction, a probe (0.3B2 of Fig .
2) 4 kb upstream and centromeric of the 0.3N probe, and
thereforepresumably centromeric to the breakpoint, identified
a unique 10-kb HindIII fragment in DNA from patient 1
in addition to the germline 21-kb fragment (Fig . 2) . As this
patient's karyotype demonstrated a balanced translocation,
we presumed that the unique 17- and 10-kb HindIII frag-
ments were derived from the two reciprocally translocated
chromosomes .
Genomic Southern blots of leukemic blasts from the pa-
tient 2, whichhadaBcell precursorimmunophenotype, failed
Immunophenotyping was performed as previously described (15) . Organomegaly was assessed by palpation of liver/spleen (in centimeters) below
right and left costal margin, respectively .
Patient Karyotype Age
yr
Sex WBC
x 10 9/liter
Hgb
g/dl
Platelet
x 109/liter
Fab
subtype Immunophenotype
Liver/
spleen
cm
1 46, XY, t(1 ;3)(p34 ; p21)/ 16.1 M 163.0 16.1 131 Ll T-cell 8/9
46, XY, -13,
+der(13)t(13 ;?)(q34;?),
t(1 ;3)(p34;p21)
2 45,X,- X,del(6)(g13g21), 11 .1 F 3.0 11.7 371 Ll Early pre-B 0/0Figure 1 .
￿
Karyotype of leukemic blasts from patient 1 . The 1p and 3p
breakpoints are indicated with arrows .
to demonstrate any rearranged bandswhen hybridized to the
chromosome 1 probes described above (data not shown) .
Isolation ofthe Germline and Translocated Alleles.
￿
A phage
library created from genomicDNA from the leukemic blasts
Figure 2 .
￿
(A) Southern blots demonstrating rearranged bands inDNA
from patient 1 . GenomicDNA from patient 1, thymus, and placenta was
digested with HindIII and Southern blotted . (Left) Southern blot hybrid-
ized to the 0.3N probe; (right) the same blot, stripped, and rehybridized
to the 0.3B2 probe. The rearranged bands are indicated by arrows ; size
standards are in kilobases. (B) Restriction map ofthe germline SCL locus .
The chromosome 1 centromere is to the left, the telomere is on the right .
Exons la-VI are indicated with open boxes representing 5' and 3' untrans-
lated regions, and filledboxes indicating coding sequences. The SCL break-
points for SIL/SCL typeA and B rearrangements (6, 7), as well as several
t(1;14) translocations (1, 4, 9), are indicated with arrows ; the breakpoint
for a patient with a SCL disruption due to a t(1 ;7) is -35 kb 3' of exon
VI (12) . Probes used (0.3B2, 0.3N, 2.2XX, and 1.OSX) for Southern hybridi-
zations are indicated below the map. Restriction sites are indicated by :
R, EcoRl ; B, BamHI; and H, HindiII . The BamHI site in parentheses
is known to be polymorphic .
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of patient 1 was screened with an SCL (0.3N) probe. 10 6
recombinant phage were plated with the Escherichia coli strain
LE 392 and screened with the 0.3N probe; no hybridizing
plaques were identified . 106 recombinants were then plated
on SRB (Stratagene) cells, an E. coli strain that has modifica-
tions (mcrA - , mcrB - , and mrr - ) reported to increase the
yield of recombinant phage clones containing methylated
DNA as well as increase the stability of nonstandard DNA
structures . 10 independent hybridizing plaques were identified
from this screen and purified . The hybridizing phage con-
tained either a 7-kb (germline) or a 14-kb (rearranged) EcoRI
fragment . These EcoRI fragments were subcloned into
plasmids for further analysis . Fig . 3A demonstrates that the
restriction maps for these two fragments are colinear and then
diverge centromeric to the SstI site, suggesting that the break-
point fallsjust upstream of this restriction site . On Southern
blots of patient 1 genomic DNA, a probe (0.7 NP, Fig. 3
A) -8 kb centromeric to this breakpoint hybridized to this
14-kb rearranged fragment in addition to an 11.5-kb frag-
ment . This probe hybridized to only the 11.5-kb fragment
inhuman placental DNA, indicating that this was the germ-
line EcoRI fragment . This 0.7 NP probe wasmapped to chro-
mosome 3 using a somatic cell hybrid panel (Table 2) . The
genomic library from patient 1 was screened with the 0.7
NP chromosome 3 probe in order to obtain the germline
chromosome 3 sequences in the vicinity of the breakpoint .
The 0.3B2 chromosome 1 probe, which identified the
reciprocal translocation (Fig. 2), was used to isolate the recipro-
cally rearranged chromosomal region . Restriction maps of
clones representing the germline and translocated alleles are
shown in Fig. 3 A .
The 5' region of the SCL locus is proximal to the centro-
mere, and the patient 1 breakpoint is in the 5' (centromeric)
portion of theSCL locus. Thus, the 14-kb rearrangedEcoRI
fragment, which hybridized to the 0.7NP chromosome 3
probe and the 0.3N chromosome 1 probe, consists of chro-
mosome 3 sequences at its centromeric portion and chromo-
some 1 sequences at its telomeric portion, and therefore
represents the derivative 3 chromosome. The reciprocally rear-
ranged 3.5-kb EcoRI fragment identified by the 0.3B2 probe
represents the derivative 1 chromosome.
Nucleotide Sequence of the Germline and Translocated Chro-
mosomes. The nucleotide sequence of thejunctional region
ofthe two derivative and two germline chromosomes is shown
in Fig . 3B . There are several noteworthy features of the se-
quence surrounding the breakpoint . The translocation was
not a perfectly conservative reciprocal translocation, as a 65-
bp sequence from chromosome 1 had been duplicated, and
is found on both the derivative 1 and 3 chromosomes as well
as the germline chromosome 1 . In addition, an -600-bp se-
quence from chromosome 3 had been deleted. The 65-bp se-
quence on germline chromosome 1 is flanked by close matches
(5/7 and 6/7 nucleotides) for the consensus V(D)J recom-
binase heptamer recognition sequence (CACA/TGTG) . The
3' heptamer has an ATrich nonamer-like motif 23 by down-
stream, while the 5' heptamer is associated with a nonamer
motif 12 by upstream . This alignment (nonamer-spacer-heptamer coding sequence heptamer-spacer-nonamer) is
reminiscent of the sequences flanking D (diversity) regions
in the TCR 6 and (3 loci. There are short stretches of non-
templated nucleotides, consistent with N-region addition,
seen at both the derivative 1 and 3 breakpoint junctions. The
germline chromosome 3 and the derivative 1 sequences di-
verge within a 94-bp tract of alternating purine and pyrimi-
dine residues that is predicted to form a region of "Z" DNA,
reported to be prone to recombination events (21-24) . There
are thus two distinct breakpoints on the germline chromo-
some 3 separated by -600 bp, which has been deleted, pre-
sumably at the time of translocation . At thejunction ofchro-
mosome 3 and 1 sequences on the derivative 3 chromosome
an inverted repeat is formed, with 6/7 and 10/14 nucleotides
forming perfect homology (Fig . 3 B) .
Leukemic Blastsfrom Patient 1 Express High Levels ofSCL
mRNA . While we do not detect SCL mRNA in periph-
eral T lymphocytes or thymocytes from normal individuals,
T cell ALL cell lines and leukemic blasts from T cell ALL
patients often express easily detectable levels ofSCLmRNA;
samples that demonstrate SCL breakpoints uniformly express
high levels ofSCLmRNA (1, 2, 7, 9, 13) . We used Northern
blot analysis to investigate whether the leukemic blasts from
either of these two patients with t(1;3) expressed an SCL
transcript . The patient with an SCL disruption (patient 1)
1306 SCL Gene Disruption in T Cell Acute Lymphoblastic Leukemia
Figure 3 .
￿
(A) Restriction map of
the translocated alleles. Germline
chromosome 1, derivative chromo-
somes 1 and 3 from the t(1 ;3), and
germline chromosome 3 EcoRI
fragments were subcloned into pBlue-
script (plasmids p3 .3, PR8, p1 .5,
and p1C, respectively) . The restric-
tion maps are oriented with the cen-
tromere on the left, and the telo-
mere on the right . Filled bars
indicate chromosome one sequences,
and hatched bars indicate chromo-
some three sequences. Probes 0.3B2,
0.3N, and0.7NP are indicated . Re-
striction sites are indicated by: R,
EcoRl; S, SstI ; and B, BamH1 . (B)
Nucleoiide sequence at the break-
point(s) . Chromosome 1 sequences
are unboxed ; chromosome 3 se-
quences are boxed . The 65-bp dupli-
cated region of chromosome 1 is
offset by gaps. The heptamer motifs
are in bold type and underlined . The
nontemplated nucleotides added at
the breakpoints are indicated in
lower-case letters. The inverted re-
peat (6/7 or 10/14 nucleotides) re-
gion at the derivative 3 junction is
indicated (+) . The -600 by of
chromosome 3 deleted by the trans-
location event is offset by slashes .
The tract ofalternating purine and
pyrimidine (Pu/py) residues dis-
rupted by the derivative 1 break-
point is evident.
expressedSCL at easily detectable levels. In contrast, patient
2, with a germline SCL locus, did not express levels ofSCL
mRNA that could be detected by Northern blot analysis
(Fig. 4) .
A Novel Transcript Unit Is Detected within 8 kb of the SCL
Breakpoint . In an effort to detect a transcript unit on chro-
mosome 3 disrupted by the translocation, we isolated probes
from chromosome 3 flanking the SCL breakpoint detected
in patient 1 . However, all of the probes isolated from the
region immediately centromeric or telomeric of the break-
point contained highly reiterated sequences, and therefore were
not useful for screening Northern blots . Reduced stringency
hybridization demonstrated that a single-copy chromosome
3 probe (UNP), located 8 kb centromeric to the breakpoint,
was conserved across species (monkey, mouse, hamster,
chicken ; data not shown), and therefore a likely candidate
gene. Two hybridizing mRNA species, of -4.0 and -2.5
kb, were expressed at varying levels in RNA from thymus
and the T cell lines SUPT1 (25) and Molt4 (26) (Fig . 5) .
This probe also hybridized to a 2.5-kb mRNA present in
leukemic blasts from patient 1 (data not shown) . Nucleotide
sequence analysis of a partial cDNA from an SUPT1 library
and comparison with the GenBank and EMBL databases re-
veals that this gene has not been previously cloned and reported
(P. D . Aplan and I . R . Kirsch, unpublished results) .Human/rodent somatic cell hybrid DNA was obtained from the NIGMS Human Genetic Mutant Cell Repository (Coriell Institute for Medical
Research, Camden, NJ), digested with EcoRI, and Southern transferred . Parental human (NAIMR91), Chinese hamster (NA10908), and mouse
(NA00347A)DNA were digested as controls . The blot was hybridized to the 0.7NP probe, and each cell line was scored for the presence or absence
of the germline 11 .5-kb EcoRI fragment . The percentages of cells with humanchromosomes represent averages of cytogenetic analysis for at least
25 cells examined at both first passage and final harvest . A perfect concordance between presence or absence of human chromosome 3 and the0.7NP
probe is evident in this panel .
Discussion
One mechanism by which chromosomal translocations as-
sociated with lymphoid neoplasms are thought to transform
cells is by "activating", or dysregulating aknown or presump-
tive cellular proto-oncogene . SCL gene disruptions are the
most common structural abnormality yet recognized to occur
Figure 4 .
￿
SCLmRNA expression.
Total RNA from the leukemic blasts
of patients 1 and2was size fraction-
ated, Northern blotted, and hybrid-
ized to an SCLcDNA probe (0.9 PX
of reference 10) . A broad band of
4.5-5.0 kb, similar in size to the
normal SCL message, is seen in the
Patient 1 lane. Migration of the 28S
and 18S ribosomalRNA is indicated .
Integrity of the RNA is demonstrated
by rehybridization to a GAPDH
probe .
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in T cell ALL (6, 7) . With this work, we have reported the
initial characterization of a new kind oftranslocation affecting
the SCL gene: a t(1;3)(p34;p21) . Similar to the previously
reported SCL translocations, the t(1;3) translocation disrupting
SCL reported here is found in a T cell (as opposed to B cell
or myeloid) acute leukemia, results inSCL expression (which
Figure 5.
￿
The chromosome 3
probe identifies a transcript . Total
RNA from thymus or the T cell
lines Molt4 and SUPT1 was size
fractionated, Northern blotted,
and hybridized to a nonreiterated
chromosome 3 probe (0.7NP)
from the vicinity of the break-
point. Migration of the 28S and
18S ribosomalRNAbands is in-
dicated . Bands of -4.0 and x+2.5
kb are indicated by arrows. Al-
though difficult to appreciate, a
band of 2.5 kb is clearly seen in
both the Molt4 andthymus lanes
on the original autoradiograph .
Table 2 . Somatic Cell Hybrid Mapping of the t(1;3)(p34;p21) Breakpoint
Percentage of cells with human chromosome :
Hybridization
Cell line to 0.7 NP 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 X Y
GM/10253 + 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
GM/NA09926 + 69 75 75 65 2 88 85 69 0 68 0 2 77 73 93 2 81 75 84 96 2 4 2 0
GM/NA09927 + 69 83 75 77 0 93 79 73 0 82 0 0 77 79 90 0 81 73 87 89 0 0 0 0
GM/NA09928 + 0 84 58 0 48 32 0 66 0 2 0 0 4 76 92 0 98 0 28 0 70 82 0 78
GM/NA09929 + 0 0 61 59 0 43 2 49 0 0 33 49 0 59 2 0 96 0 2 31 0 0 2 0
GM/NA09930 + 0 34 62 4 12 0 26 4 0 0 6 22 56 82 12 0 86 78 0 22 82 76 6 8
GM/NA09933 + 50 0 84 16 54 76 92 54 0 6 0 50 84 78 92 0 88 70 80 32 94 88 0 32
GM/NA09935 + 0 0 52 10 28 12 0 0 0 8 0 22 74 72 0 0 93 59 0 9 91 71 0 0
GM/NA09937 + 0 0 54 38 0 62 54 70 0 4 0 42 0 70 60 0 96 66 0 0 0 0 0 0
GM06318B - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0
GM10479 - 0 0 0 0 0 0 0 0 0 0 0 0 0 88 0 0 0 0 0 0 0 0 0 0
GM/NA09925 - 74 24 0 74 76 60 82 78 0 0 4 68 6 86 78 14 98 96 46 84 0 76 0 0
GM/NA09931 - 0 0 0 0 26 0 78 0 0 46 0 64 0 100 0 0 100 0 0 78 90 0 0 14
GM/NA09932 - 0 0 0 68 86 46 0 80 0 2 28 26 0 0 0 0 96 0 2 0 92 0 0 0
GM/NA09934 - 0 50 0 0 83 79 4 87 0 0 77 87 0 2 89 0 90 89 0 91 89 2 0 0
GM/NA09936 - 0 0 0 18 0 46 70 10 0 16 34 0 2 88 2 0 100 0 44 24 0 18 0 0is not usually detected in T cells), and seems to have been
mediated, at least in part, by the action of the V(D)J recom-
binase complex, without involvement of a TCR locus . The
other case with a t(1;3) that we evaluated had aB cell precursor
immunophenotype and showed neither SCL gene rearrange-
ments (by conventional genomic Southern blot analysis) nor
SCL mRNA expression, suggesting a distant breakpoint
at the molecular level and strengthening the observation
that SCL gene disruptions are highly specific for T-lineage
leukemias.
A well-knownmechanism for chromosomal translocation
associated with lymphoid neoplasms juxtaposes an antigen
receptor (Ig orTCR) gene on one chromosome with a known
or presumptive cellular proto-oncogene (such as c-myc or bcl-2)
present on the other chromosome (see reference 27 for re-
view) . The frequent involvement of antigen receptor loci,
which physiologically undergo intralocus V(D)J gene rear-
rangements in the process of generating immunologic diver-
sity, has ledmany to speculate that the translocations associated
with lymphoid neoplasms are the result of abnormal genomic
rearrangements mediated by aberrant V(D)J recombinase ac-
tivity (see reference 28 for review) . Often, although not always,
hallmarks of normal V(D)J recombinase activity (29), such
as heptamer (sometimes associated with nonamer) signal se-
quences, nontemplated or "N" region nucleotide addition,
and exonucleolytic "nibbling", are found in the vicinity of
the breakpoints. In several cases, including one involving the
SCL gene (12), where heptamer-like sequences have not been
found in the vicinity of the breakpoints, investigators have
noted tracts of alternating purine and pyrimidine residues
(Pu/Py) within 900 nucleotides of the breakpoints (12, 21,
30) . It has been proposed that the alternating Pu/Py residues,
which can exist as left-handed orZ DNA, may also be prone
to recombination events (possibly targeted because of tertiary
chromatin structure) (21-24), and may serve as a functional
alternative to heptamer recognition sequences in the context
of V(D)J recombinase-associated translocations (21) .
Sequence analysis of this t(1;3) shows several of the hallmarks
of normal V(D)J recombination, such as heptamer signal se-
quences on chromosome 1 in the vicinity ofboth the deriva-
tive 1 and 3 breakpoints, along with nontemplated N region
nucleotide addition at the breakpoints . Although the germ-
line chromosome 3 does not have heptamer sequences near
the breakpoints, there is a remarkable run of 94 consecutive
alternating purine and pyrimidine residues, which is disrupted
by the derivative 1 breakpoint (Fig . 3 B) . Therefore, consis-
tent with previous reports, it is possible that this transloca-
tion was mediated, at least in part, by the V(D)J recombinase
aberrantly targeting two cryptic heptamer recognition se-
quences on chromosome 1 and a region ofZDNA formed
by Pu/Py tracts on chromosome 3 . The 65 nucleotides of
chromosome 1 bracketed by the derivative 1 and 3 break-
points may have been duplicated in the process of repairing
a staggered nick on chromosome 1 generated by the translo-
cation . In addition, the presence of an inverted repeat sequence
precisely at the derivative 3 breakpoint suggests that this re-
gion ofhomology may have targeted the derivative 3 break-
point onchromosome 3 . Similar to the mechanism proposed
for the SIL/SCL rearrangement, a site-specific deletion that
juxtaposes the SIL gene with SCL in 16-26% of patients
with T cell ALL (6, 13), the V(D)J recombinase complex
can be implicated in the generation of this t(1;3) transloca-
tion. This reinforces the notion thatwhen the V(D)J recom-
binase complex is active, cryptic heptamer sequences may target
aberrant V(D)J recombination events between nonantigen
receptor genes.
This t(1;3)(p34;p21) translocation has identified a previ-
ously undescribed transcript unit on chromosome 3 . Since
the chromosome 3 transcript identified by the 0.7 NP probe
is expressed in thymus and T cell lines (Fig . 5), it is possible
that expression ofSCL is being driven by the promoter/en-
hancer of the chromosome 3 gene. This situation would be
similar to the other SCL translocations and deletions, where
SCL expression seems to be dysregulated by promoter/en-
hancer elements of the TCRD (1, 2, 9), TCRB (12), or SIL
(13, 14, and P.D. Aplan, D.P. Lombardi, and I.R . Kirsch,
unpublished results) .
With this report, there are now at least four general types
of SCL disruptions recognized to be associated with acute
leukemia ; the SIL/SCL rearrangement resulting in a cytoge-
netically undetectable interstitial deletion ofchromosome 1,
and translocations between SCL andTCRD [t(1;14)], TCRB
[t(1;7)], and an uncharacterized transcribed locus on chro-
mosome 3p21 . The similarities among these genomic rear-
rangements are striking. All these rearrangements are strongly
associated with T cell (as opposed to B cell or myeloid)
leukemias, all seem to be mediated, at least in part, by the
V(D)J recombinase complex, all juxtapose SCL with a gene
normally expressed in thymocytes, and all result in inap-
propriate expression of SCL mRNA . Though we have yet
to demonstrate a direct tumorigenic effect of SCL, it is
tempting to speculate that SCL is acting as a dominant on-
cogene in T cell ALL .
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